Bisolvon Drank cough syrup

Bisolvon is a globally recognized brand specializing in respiratory health products, particularly known for its mucolytic treatments that help clear chest congestion. The active ingredient in this product is bromhexine hydrochloride, which was originally developed by the German pharmaceutical company Boehringer Ingelheim in the 1960s. The brand has a long-standing history of providing relief for productive coughs by thinning mucus to make it easier to expel.

In 2017, as part of a significant strategic asset swap, Boehringer Ingelheim traded its consumer healthcare business, which included the Bisolvon brand, to the French pharmaceutical giant Sanofi. Since then, Sanofi has acted as the ultimate owner, managing the brand through its global Consumer Healthcare division, which is being evolved into a standalone business unit called Opella. Manufacturing for Bisolvon takes place in various specialized pharmaceutical facilities across Europe and other regions to meet global demand.